Physicians'​ Education Resource

Verified
Journal
Physicians' Education Resource®, LLC (PER®) is dedicated to advancing cancer care through professional education. Accredited by the Accreditation Council for Continuing Medical Education (ACCME) and approved as a nursing continuing education provider by the California Board of Registered Nursing (CBRN), PER® is the educational resource of choice for live and online activities focusing on oncology and hematology. Based on identified needs and practice gaps, PER® provides high-quality, evidence based activities featuring leading national and international faculty with a focus on practice changing advances and standards of care in treatment and disease management. Activities may also include topics on emerging strategies currently under investigation, supportive care, diagnosis and staging, prevention, screening and early detection, and practice management. Source

Actions

Share this page

Media Outlet details

Scope National
Language English
Country United States of America
Similarweb UVMSimilarweb UVM Request pricing
Comscore UVMComscore UVM Request pricing
Accepts contributed content Yes

Recent Articles

Search

A Community-Based Roadmap to CAR-T Therapy: Optimizing Delivery and Outcomes

| Physicians'​ Education Resource Verified
This educational activity is directed toward medical/hematologists oncologists, hematologists, advanced practice providers, nurses, and other HCPs involved in the management of hematologic malignancies.
Open in Who Shared Issue with article?

Oncology Town Hall: Updates From Berlin: Oral SERDs in HR+/HER2– Metastatic Breast Cancer—What the Latest Data Really Tell Us

| Physicians'​ Education Resource Verified
Accreditation/Credit Designation Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Open in Who Shared Issue with article?

Hematologic Malignancies

| Physicians'​ Education Resource Verified
Open in Who Shared Issue with article?

Show Me the Data®: From Mutation to Action — KRAS as a Therapeutic Target in PDAC

| Physicians'​ Education Resource Verified
Activity Overview This online, on-demand virtual symposium brings together renowned experts in advanced pancreatic ductal adenocarcinoma (PDAC). In this educational program, these experts discuss emerging approaches to target KRAS in advanced PDAC, framed in the discussion of challenging case scenarios where novel treatments could fit. This educational activity is an archive of the live symposium held on April 11, 2026.
Open in Who Shared Issue with article?

Innovative Cancer Therapy for Tomorrow™

| Physicians'​ Education Resource Verified
Open in Who Shared Issue with article?

30th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma - Learning Hub

| Physicians'​ Education Resource Verified
Stay up to date with the latest advances in hematologic malignancies through the 30th Annual International Congress on Hematologic Malignancies® Learning Hub. Designed for easy, on-demand access, the hub features expert-led presentations, slides, and videos covering key updates across AML, NDMM, CML, DLBCL, and more.
Open in Who Shared Issue with article?

Practical Strategies for Monitoring and Managing Toxicities With Novel Therapies for HER2-Positive Gastroesophageal Adenocarcinoma

| Physicians'​ Education Resource Verified
Overview: The management of esophagogastric adenocarcinoma has evolved substantially with the introduction of effective targeted and immunologic therapies. However, these therapies are appropriate mainly for patients with specific biomarkers, necessitating careful coordination among the multidisciplinary team to ensure proper tissue stewardship and testing, which in turn allows for appropriate treatment selection and sequencing, as well as management and mitigation of adverse events.
Open in Who Shared View Duplicates (2) Issue with article?

Optimizing HER2 Testing in Gastroesophageal Adenocarcinoma: Laying the Foundation for Targeted Therapy

| Physicians'​ Education Resource Verified
Overview: The management of esophagogastric adenocarcinoma has evolved substantially with the introduction of effective targeted and immunologic therapies. However, these therapies are appropriate mainly for patients with specific biomarkers, necessitating careful coordination among the multidisciplinary team to ensure proper tissue stewardship and testing, which in turn allows for appropriate treatment selection and sequencing, as well as management and mitigation of adverse events.
Open in Who Shared View Duplicates (2) Issue with article?

Cases and Conversations™: Integrating PSMA-Directed Radioligand Therapy in Prostate Cancer Care: Recent Data and Evolving Strategies

| Physicians'​ Education Resource Verified
Accreditation/Credit Designation Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Open in Who Shared Issue with article?

Medical Crossfire® — From Diagnostic Dilemmas to Potential Treatment Breakthroughs: Exploring Novel Targets for Extrapulmonary Neuroendocrine Carcinomas

| Physicians'​ Education Resource Verified
Accreditation/Credit Designation Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Open in Who Shared Issue with article?